Delving into the Latest Updates on Medsearch Technologies, Inc. with Synapse

概览

关联

1

项与 Medsearch Technologies, Inc. 相关的药物

Wobe-Mugos E(NCI)

靶点-

作用机制

酶替代物

在研机构-

原研机构

National Cancer Institute

在研适应症-

非在研适应症

多发性骨髓瘤

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

1

项与 Medsearch Technologies, Inc. 相关的临床试验

NCT00014339

/ Unknown status临床3期

A Randomized, Phase III, Placebo-Controlled Multicenter Study to Demonstrate the Effectiveness and Safety of the Combination Enzyme Tablet (Wobe-Mugos E) as Adjuvant Therapy to Standard of Care Treatment in Patients With Stages II or III Multiple Myeloma

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Enzyme products such as Wobe-Mugos E may help to reduce the side effects of multiple myeloma therapy. It is not yet known if chemotherapy is more effective with or without Wobe-Mugos E in treating multiple myeloma.
PURPOSE: Randomized phase III trial to compare the effectiveness of chemotherapy with or without Wobe-Mugos E in treating patients who have stage II or stage III multiple myeloma.

开始日期2000-03-01

申办/合作机构

Medsearch Technologies, Inc.

100 项与 Medsearch Technologies, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Medsearch Technologies, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Medsearch Technologies, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Medsearch Technologies, Inc. 相关的转化医学

登录后查看更多信息